Livelively USA combines AI insights with Eastern wellness principles to support healthier long-term weight management behaviors.
NEW YORK, Dec. 22, 2025 /PRNewswire/ -- Weight-loss medications are reshaping global healthcare, with the anti-obesity drug market projected to approach $100 billion by 2030, according to Goldman Sachs. As millions begin GLP-1 therapy, interest is growing around how to maintain strength, vitality, and well-being throughout treatment.
Livelively USA Inc. today introduced a metabolic wellness platform that integrates predictive AI with Integrative Longevity Science—focusing on circadian rhythms and somatic balance—to help GLP-1 users stay engaged in supportive nutrition, movement, and daily routines while working toward long-term health goals.
More than 37 million Americans currently use GLP-1 agonists such as Wegovy and Zepbound. Public health data shows many users struggle with consistency over time. Clinical literature also highlights that factors like nutrition, muscle maintenance, movement, and sleep play an important role in supporting well-being during weight loss. Livelively aims to make these supportive behaviors easier to access and sustain.
Livelively's Approach: Western Technology Meets Eastern Wellness
"Most weight-loss tools track calories or steps, but people need help making holistic lifestyle changes," says Changdae Chi, CEO of Livelively USA. "By combining generative AI insights with Eastern wellness philosophy, our platform encourages habits that support sustainable vitality—not just weight reduction."
Key Elements
Protein-First Vision AI:
Analyzes meal composition to ensure adequate protein intake, critical for preventing muscle loss.
Daily Rhythm Guidance:
The platform offers Metabolic Recovery Protocols inspired by Asian Longevity Medicine, emphasizing circadian alignment and muscle resilience.
AI-Driven Insight Prompts:
Predictive patterns within user-reported data help surface gentle reminders around movement, hydration, rest, and nutrition—behaviors associated with overall metabolic health.
Early User Engagement Indicators
In an initial pilot program involving high-performance professionals in Silicon Valley—who often face irregular lifestyle patterns and metabolic stress—participants demonstrated strong engagement with the platform's daily routines and nutritional guidance.
Preliminary indicators suggested:
- High ongoing participation rates relative to typical digital wellness tools
- Positive user-reported experience with strength-supportive behaviors
These early results reflect user engagement—not clinical outcomes—and will inform future research.
Headquartered at One Penn Plaza (Penn 1) in New York, Livelively USA is participating in Plug and Play Tech Center's GOAL accelerator program. The company is developing partnerships with metabolic clinics and healthcare organizations to further evaluate how lifestyle support may enhance the user experience during GLP-1 treatment.
About Livelively USA Inc. Founded in 2024, Livelively USA is a healthtech innovator fusing South Korea's advanced IT infrastructure with the time-honored wisdom of Eastern Longevity Medicine. The company provides accessible, human-centric digital therapeutics for the global obesity and diabetes market.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
AI Platform to Combat Muscle Loss and Preserve Metabolic Vitality for GLP-1 Users
SHANGHAI, April 2, 2026 /PRNewswire/ -- Orka, a pioneer in hearing health technology, officially launched the Orka O1 Pro at the 2026 Appliance & Electronics World Expo (AWE). The Orka O1 Pro is the world's first Receiver-in-Canal (RIC) hearing aid to feature Powered by Bose QuietControl Active Noise Cancellation (ANC) technology.
The launch took place at the Eastern Hub International Business Cooperation Zone during AWE 2026's inaugural international showcase. As a new gateway designed to support global exchange and cross-border collaboration, the Eastern Hub provided a fitting stage for Orka's global debut. Orka was the only hearing health company featured alongside leading technology brands including Sony, LG, and Lenovo, a placement that reflects the international ambition of the Orka × Bose partnership and Orka's broader mission to bring hearing health into the mainstream of global consumer technology innovation.
Bringing Premium Audio Innovations to Hearing Health
As recently noted by Hearing Tracker, while Active Noise Cancellation (ANC) is familiar to millions of consumers from premium headphones, the Orka O1 Pro answers the highly anticipated question of its future in hearing aids.
The device achieves this through the seamless integration of two powerhouse features, heavily supported by Bose's decade of research. First, Bose QuietControl ANC technology acts as the foundation, effectively neutralizing steady-state environmental noises before they reach the ear. Working in perfect tandem, Bose SpeechClarity Voice technology precisely isolates and enhances human speech, ensuring that once the background noise is silenced, essential conversations remain crystal clear.
This collaboration brings powerful, premium audio experiences to users without the battery and processing tradeoffs typically associated with such features, helping make the O1 Pro a true all-day wearable device.
A Milestone in Hearing Health
"For years, we've been focused on the real-world challenges of hearing loss, especially how background noise can make conversations more difficult," said Nicholas Smith, President of the Audio Technology Business and Chief Strategy Officer at Bose. "We saw the potential for our noise cancellation technology to improve this experience, and we knew we needed a partner capable of bringing this kind of breakthrough to the hearing industry. That's why we partnered with Orka."
Smith further emphasized the impact: "Orka integrated our core technology into a complete hearing aid experience engineered for reliable performance in real-world environments. The result is clearer conversations and less effort required to hear — so people can stay in the conversation and stay connected."
Restoring Control and Energy
The Orka O1 Pro hardware is designed for maximum comfort and durability. Weighing just 3.5g per earpiece, it features Bluetooth 5.3 dual-mode connectivity, IP68 durability, and provides over 35 hours of continuous battery life.
In Icelandic, "Orka" translates to "energy." The core philosophy behind the Orka O1 Pro is to significantly reduce the cognitive load and energy drain required to focus in noisy environments. By lowering the effort required to hear, the device returns a sense of control and confidence to the user.
About Orka
Founded in Silicon Valley in 2018, Orka is a premium audiology technology company developing AI-driven products for the future of hearing and wearable listening. Backed by top-tier investors including Tencent, HongShan (formerly Sequoia Capital China), Primavera Capital, and Atypical Ventures, Orka integrates advanced acoustic hardware with proprietary on-device AI to create beautifully designed, all-day wearables. Recognized globally by the CES Innovation and Red Dot Design Awards, the company's mission is rooted in its Icelandic name, meaning "energy": to significantly reduce the cognitive load required to hear in noise, returning a sense of control and confidence to every user.
For more information about Orka and the O1 Pro, please email contact@hiorka.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Orka O1 Pro Makes Global Debut at AWE 2026: The World's First Hearing Aid with Powered by Bose QuietControl ANC Technology
Orka O1 Pro Makes Global Debut at AWE 2026: The World's First Hearing Aid with Powered by Bose QuietControl ANC Technology
Orka O1 Pro Makes Global Debut at AWE 2026: The World's First Hearing Aid with Powered by Bose QuietControl ANC Technology
